Hepatitis, Viral, Human clinical trials

The registry lists 43 studies for Hepatitis, Viral, Human across more than 10 countries. 3 are recruiting or about to start. 7 of them are mainly about Hepatitis, Viral, Human (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-29. Counting its 8 narrower conditions too, such as Hepatitis C: 4,211 studies, 368 open.

Get an email when these change. Save the Hepatitis, Viral, Human studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 34
Terminated: 3
Recruiting: 2
Enrolling by invitation: 1
Approved for marketing: 1
Status unknown: 1

Phase

Phase 3: 10
Phase 2: 6
Phase 1: 5
Phase 4: 2

Where

United States: 14
France: 5
Spain: 5
China: 4
United Kingdom: 3
Italy: 3

Who runs them

Gilead Sciences (8) · National Heart, Lung, and Blood Institute (NHLBI) (5) · AusperBio Therapeutics Inc. (2) · Merck Sharp & Dohme LLC (2) · National Cancer Institute (NCI) (2) · University of Ulm (2) · University of North Carolina, Chapel Hill (2) · Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León (1)

What is being tested here

Drugs under test in Hepatitis, Viral, Human studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Hepatitis B Virus Antisense Oligonucleotide AHB-137	2	0	2
Ribavirin	0	1	2
Sofosbuvir	0	1	2
Voxilaprevir	0	0	1
Bemnifosbuvir	0	0	1
Elbasvir	0	0	1
Daclatasvir	0	0	1
Asunaprevir	0	0	1
Beclabuvir	0	0	1
Polyethylene Glycols	0	0	1

Coming up

0phase 3 studies under way

1study finishes main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The study

May 2027Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions · AusperBio Therapeutics Inc.

Who these studies take

Of the 2 Hepatitis, Viral, Human studies recruiting now, 0 (0%) set no upper age limit and 2 (100%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 2
Age	Women	Men
10	0 (0%)	0 (0%)
18	2 (100%)	2 (100%)
30	2 (100%)	2 (100%)
40	2 (100%)	2 (100%)
50	2 (100%)	2 (100%)
65	2 (100%)	2 (100%)
75	0 (0%)	0 (0%)
85	0 (0%)	0 (0%)

Across all 43 studies, recruiting or not: 40% stop at 75 or younger and 35% at 65; 26% take children; 0% are for women only and 21% for men only; 19% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 43 of 43. search them.